JOURNAL
Current Issue
Journal Archive
.............................................................
March 2019 -
Volume 17, Issue 2

View this issue in pdf format

........................................................
From the Editor

........................................................

 

Editorial

Dr. Abdulrazak Abyad
DOI: 10.5742/MEWFM.2019.93623

Original Contribution

Self-monitoring of Blood Glucose Among Type-2 Diabetic Patients: An Analytical Cross-Sectional Study
[pdf]
Ahmed S. Alzahrani, Rishi K. Bharti, Hassan M. Al-musa, Shweta Chaudhary
DOI: 10.5742/MEWFM.2019.93624

White coat hypertension may actually be an acute phase reactant in the body
[pdf]
Mehmet Rami Helvaci, Orhan Ayyildiz, Orhan Ekrem Muftuoglu, Mehmet Gundogdu, Abdulrazak Abyad, Lesley Pocock
DOI: 10.5742/MEWFM.2019.93625

Case Report

An Unusual Persistent Mullerian Duct Syndrome in a child in Abha city: A Case Report
[pdf]
Youssef Ali Mohamad Alqahtani, Abdulrazak Tamim Abdulrazak, Hessa Gilban, Rasha Mirdad, Ashwaq Y. Asiri, Rishi Kumar Bharti, Shweta Chaudhary
DOI: 10.5742/MEWFM.2019.93628

Population and Community Studies

Prevalence of abdominal obesity and its associated comorbid condition in adult Yemeni people of Sana’a City
[pdf]
Mohammed Ahmed Bamashmos
DOI: 10.5742/MEWFM.2019.93626

Smoking may even cause irritable bowel syndrome
[pdf]
Mehmet Rami Helvaci, Guner Dede, Yasin Yildirim, Semih Salaz, Abdulrazak Abyad, Lesley Pocock
DOI: 10.5742/MEWFM.2019.93629

Systematic literature review on early onset dementia
[pdf]
Wendy Eskine
DOI: 10.5742/MEWFM.2019.93627



Middle East Quality Improvement Program
(MEQUIP QI&CPD)

Chief Editor -
Abdulrazak Abyad MD, MPH, MBA, AGSF, AFCHSE

.........................................................

Publisher -
Lesley Pocock
medi+WORLD International
AUSTRALIA
Email
: lesleypocock@mediworld.com.au
.........................................................

Editorial Enquiries -
abyad@cyberia.net.lb
.........................................................

Advertising Enquiries -
lesleypocock@mediworld.com.au
.........................................................

While all efforts have been made to ensure the accuracy of the information in this journal, opinions expressed are those of the authors and do not necessarily reflect the views of The Publishers, Editor or the Editorial Board. The publishers, Editor and Editorial Board cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; or the views and opinions expressed. Publication of any advertisements does not constitute any endorsement by the Publishers and Editors of the product advertised.

The contents of this journal are copyright. Apart from any fair dealing for purposes of private study, research, criticism or review, as permitted under the Australian Copyright Act, no part of this program may be reproduced without the permission of the publisher.

March 2019 - Volume 17, Issue 3

Self-monitoring of Blood Glucose Among Type-2 Diabetic Patients: An Analytical Cross-Sectional Study

Ahmed S. Alzahrani (1)
Rishi K. Bharti (2)
Hassan M. Al-musa (3)
Shweta Chaudhary (4)

(1) Family Medicine specialist, Community medicine resident, Abha, King Khalid University Saudi Arabia
(2) Assistant Professor, Community medicine consultant, Faculty of Medicine, King Khalid University,
Saudi Arabia.
(3) Associate Professor, Family Medicine consultant, Family and Community medicine department,
Faculty of medicine, King Khalid University, Saudi Arabia.
(4) Assistant Professor, Department of Anatomy, Faculty of Medicine, King Khalid University, Saudi Arabia.

Corresponding author:
Dr. Ahmed Salem Al-zahrani,
Family Medicine specialist, Community Medicine resident
Abha, King Khalid University, Saudi Arabia

Email :
ahmedalzahrani122333@gmail.com


Abstract


Background: Diabetes mellitus (DM) is a public health disease needing urgent consideration; it has a great impact on human life in addition to being costly to manage. According to the current recommendations, self-monitoring of blood glucose (SMBG) is important in order to achieve and maintain glycemic control, prevent and identify hypoglycemia, prevent severe hyperglycemia and support lifestyle changes.

Methods: The objective of this study is to explore the effect of using SMBG on glycemic control among type 2 diabetic patients attending the primary health care centers in Abha city in the Kingdom of Saudi Arabia, by comparing those who are monitoring themselves and others who are not. The study design was analytical cross-sectional and conducted through an interviewing questionnaire.

Results: The age of participants was 30-82 years old, with a mean age distribution of 57.4 years old. The percentages of groups doing and not doing SMBG were 43% and 57% respectively. Chi square tests show that the relationship between glycemic control and SMBG is statistically significant according to frequency and time of doing SMBG, since almost all of the results for the participants who do SMBG are above the target for glycemic control (>=7%). The relationship between glycemic control and compliance according to SMBG shows there is a statistically significant relationship with appointment compliance among the group doing SMBG, and with drug compliance among the other group.

In both groups, almost all the participants were above the target for control (>=7%), which means that there is no relationship between doing SMBG and better glycemic control.

Conclusion: There is not sufficient evidence to show that the self-monitoring of blood glucose is associated with an improvement in glycemic control among type 2 diabetics and it is shown that glycemic control for both groups that are using and not using SMBG is above the target. It is recommended that more well conducted randomized controlled trials should be undertaken to evaluate the relationship between SMBG and glycemic control in type 2 diabetes, at the same time the current guidelines for the use of SMBG among patients with well controlled non-insulin treated type 2 diabetes need to be reviewed.

Key words: Self-monitoring, blood glucose (SMBG), glycemic control, type 2 diabetes, comorbidities.

 

.................................................................................................................